Global life sciences leader Cytiva opens manufacturing facility in India

  • Articles
  • Oct 30,23
The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel therapeutics.
Global life sciences leader Cytiva opens manufacturing facility in India

As India works to become a biologics manufacturing hub, global life sciences leader Cytiva (now with the life sciences business from Pall Corporation) has opened a 33,000 sq ft manufacturing facility in Pune. The new facility will manufacture Cytiva’s bioprocessing equipment including tangential flow, virus filtration, and inactivation systems.

The facility will also be home to the Cytiva Experience Center which will provide immersive training programs for upstream and downstream technologies as well as digital and automation software. Additionally, customers will have greater access to thought leadership events and to demonstrations of Cytiva’s market-leading products, such as AKTA, Allegro, iCELLis and Sepax.

Rajan Sankaran, Commercial General Manager, India, Cytiva, said, “Fortifying our manufacturing footprint in India is critical to Cytiva’s operations in Asia-Pacific and long-term growth strategy. We must also play a key role in developing and nurturing the talent needed to meet the demand for biologic medicines. Our Cytiva Experience Center will provide the ongoing learning and development needed to accelerate the development of novel therapeutics and help India deliver on its Aatmanirbhar Bharat vision and mission.”

Located at Hinjawadi Rajiv Gandhi Infotech Park, this new facility complements Cytiva’s existing facilities in Bengaluru which include a Fast Trak Center, and a center for research and development across bioprocess, discovery, medical, and genomic medicine businesses.

According to Cytiva’s 2023 Global Biopharma Resilience Index, 65 per cent of biopharma executives in India say that the manufacturing of biologics in their country is likely to dramatically increase over the next three years. This is 15 per cent higher than the global average, and in line with India’s National Biopharma Mission to make India a hub for the development of novel and affordable vaccines and biologics to address the population’s health concerns.



Additionally, 46 per cent of biopharma executives in India say that they are focusing on onshoring drug manufacturing or increasing domestic sourcing over the next 12 months to boost supply chain resilience. However, 20 per cent of executives say that access to new equipment has become worse over the last two years, indicating a need to improve local access to equipment so that Indian companies can deliver affordable life-changing therapeutics domestically and to the region.

Cytiva aims to advance and accelerate the development of therapeutics. With nearly 16 000 associates in more than 40 countries, Cytiva’s broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers.

Related Stories

Process Equipment
Nirma plans Rs 3,500 cr NCDs issue for GLSL acquisition and business growth

Nirma plans Rs 3,500 cr NCDs issue for GLSL acquisition and business growth

CRISIL, the rating agency, has assigned an “AA” rating to Nirma's proposed NCDs, reaffirming ratings on the company's existing bank facilities and debt instruments.

Read more
Process Equipment
Global life sciences leader Cytiva opens manufacturing facility in India

Global life sciences leader Cytiva opens manufacturing facility in India

The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel the..

Read more
Process Equipment
Cytiva expands presence in India with cutting-edge manufacturing facility

Cytiva expands presence in India with cutting-edge manufacturing facility

The new manufacturing facility in Pune is poised to play a pivotal role in Cytiva's operations in the Asia-Pacific region.

Read more

Related Products

Programmable Controllers - Pcd-33a Series

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Pro-Med Instruments (P) Ltd offers a wide range of programmable controllers - PCD-33A Series.


Read more

Request a Quote

Gasket Graphite Powder

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Arihant Packing & Gasket Company offers a wide range of gasket graphite powder. 


Read more

Request a Quote

Asahi Kasei expands 3D printing filament sales in North America

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Asahi Kasei, a leading resin and compounding technology provider, has initiated the sales of 3D printing (3DP) filaments in North America through Asahi Kasei Plastics North America (APNA). The soft la Read more

Request a Quote

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016

Reach out to us

Call us at +91 8108603000 or

Schedule a Call Back